GLP-1 Genetic Testing

GLP-1 Genetic Testing: Genetic Context for Weight Management Medications

GLP-1 receptor agonists are widely prescribed for weight management and blood sugar control. NextGen PGx pharmacogenomic testing reports genetic variants that have been studied for possible relevance to how the body processes certain medications in this category.

Why genetics may matter with GLP-1 medications

Response to GLP-1 medications varies from person to person. While diet, activity, dose, and consistency all play a major role, researchers continue to study whether certain genetic variants are associated with differences in medication metabolism.

A PGx test does not predict weight loss outcomes or determine the right dose — it provides additional genetic context that you can discuss with your prescriber alongside your full health history.

What NextGen PGx reports

  • Gene variants studied in relation to relevant medication-processing pathways
  • Evidence-level context so you understand the strength of each finding
  • A secure report you can share directly with your prescriber

Related pages

Explore genetic testing focused on a specific medication category: semaglutide, tirzepatide, or weight loss medications generally.

FAQ

Questions, answered

Ready to learn what your genetics can tell you?

Order your NextGen PGx PGx test today and get a unique patient ID in minutes.

Related Resources

Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective manufacturers. NextGen PGx is not affiliated with, sponsored by, or endorsed by these companies.